Capstone Investment Advisors
TMDX icon

Capstone Investment Advisors’s Transmedics TMDX Stock Holding History

Capstone Investment Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$641K Buy
+9,652
New +$817K ﹤0.01% 1133
2026
Q1 		– Sell
-2,943
Closed -$358K – 1845
2025
Q4 		$358K Buy
2,943
+599
+26% +$75.2K ﹤0.01% 1273
2025
Q3 		$263K Buy
+2,344
New +$274K ﹤0.01% 1701

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Capstone Investment Advisors's TMDX Position: Q2 2026 in Review

Capstone Investment Advisors opened a new position in Transmedics (TMDX) in Q2 2026: 9,652 shares worth $641K. The stake represents ﹤0.01% of the portfolio and ranks #1133 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in TMDX as recently as Q4 2025.

Capstone Investment Advisors first reported a position in TMDX in Q3 2025 and has held it in 3 quarters since. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Capstone Investment Advisors held 9,652 shares of Transmedics worth $641K as of Q2 2026.
  • Transmedics was a new Capstone Investment Advisors position in Q2 2026.
  • Transmedics made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1133 holding.
  • Capstone Investment Advisors first reported a position in Transmedics in Q3 2025 and has held it in 3 quarters since.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.